Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Radiol Med ; 114(2): 239-52, 2009 Mar.
Article in English, Italian | MEDLINE | ID: mdl-19266257

ABSTRACT

PURPOSE: This study was done to analyse the costs of 64-slice computed tomography (CT) coronary angiography and conventional coronary angiography and determine the cost-effectiveness of the two modalities. MATERIALS AND METHODS: Detailed activity-based cost analyses of the two modalities were carried out at the departments of radiology and cardiology of a teaching hospital. The differential costs (equipment, variable, personnel), common costs and external costs were estimated. Finally, the full costs of the two procedures were obtained; the full cost of conventional coronary angiography also considered the cost of 1 day in hospital. The cost-effectiveness of the two procedures at different levels of pretest likelihood of coronary artery disease (CAD) was estimated. RESULTS: The costs of multidetector CT (MDCT) coronary angiography were as follows: differential cost 222.23 euro, common cost 5.50 euro, external cost 2.30 euro and full cost 230.03 euro. The costs of conventional coronary angiography were: differential cost 366.18 euro, common cost 0.50 euro, external cost 9.20 euro, hospitalisation cost 1,652 euro and full cost 2,027.88 euro. Cost-effectiveness analysis showed that the cost per correctly identified CAD patient decreased exponentially with increasing pretest likelihoods of CAD. MDCT coronary angiography was more cost effective than conventional coronary angiography up to a pretest likelihood of 86%. CONCLUSIONS: MDCT coronary angiography has far lower costs than conventional coronary angiography, and its cost-effectiveness is better in the large majority of patients.


Subject(s)
Coronary Angiography/economics , Coronary Angiography/methods , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/economics , Tomography, X-Ray Computed/economics , Tomography, X-Ray Computed/methods , Cost-Benefit Analysis , Humans
2.
Dig Liver Dis ; 39 Suppl 1: S52-4, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17936224

ABSTRACT

UNLABELLED: Cryoglobulinemic Syn&come (CS) is a multi-systemic disease, and its fatal evolution can involve different organs. AIMS: To describe the most frequent causes of death in CS, by researching different evolutions between older cases and those of the last 15 years. PATIENTS: The data of 238 patients affected by symptomatic cryoglobulinemia followed by our Medicine Department in the last 30 years are recorded in a database. 54 are presently living and being followed, 70 (36F, 34M) have died. The type II/type III ratio is 5/4. We distinguish between two groups, the oldest, without any data on HCV, and the most recent who were tested for HCV. The follow-up ranges from 0.5 to 16 years. RESULTS: Liver diseases (25 cases, 9 with hepatic carcinomas), lymphomas and myeloproliferative diseases (12), and cardiovascular events (8) are the most reported causes of death. Sepsis, neurological syndromes, nephropathy, other malignancies and diffuse vasculitis are also reported. The median age at death was 67.2 years (58.4 in the oldest group, 71.9 in the other). Hepatic carcinomas are reported only after 1991. CONCLUSION: Cirrhosis complications are more frequent in patients affected by HCV. The increase in instrumental diagnostic ability and the improved survival of patients with cirrhosis account for the increase in patients with hepatic carcinomas. Improved treatment has resulted in a reduction of deaths from renal failure.


Subject(s)
Cryoglobulinemia/mortality , Aged , Cause of Death , Female , Hepatitis C, Chronic/complications , Humans , Liver Cirrhosis/mortality , Liver Neoplasms/mortality , Male , Middle Aged , Renal Insufficiency/mortality
3.
Prog Urol ; 10(2): 298-9, 2000 Apr.
Article in French | MEDLINE | ID: mdl-10857152

ABSTRACT

The lithotomy position is widely used in urological surgery to obtain adequate exposure of the perineal plane. It is used, for instance, for stenosis of the posterior urethra. Fortunately, it rarely gives rise to complications although if the operation takes a long time the patient may suffer various adverse reactions; these range from simple peroneal nerve distress to thromboembolism [1, 2] and the much more serious "compartmental syndrome" [2, 3, 4]. There is still debate about the best therapeutic approach to a lesion caused by prolonged muscle compression. Some suggest immediate fasciotomy, whether others hold out for conservative treatment. We report here a case of compartmental syndrome arising in a patient who had to remain the the lithotomy position for a long time, which responded well to conservative treatment.


Subject(s)
Compartment Syndromes/etiology , Posture , Adult , Humans , Male , Time Factors
4.
Arch Ital Urol Androl ; 71(4): 241-4, 1999 Sep.
Article in Italian | MEDLINE | ID: mdl-10592539

ABSTRACT

Retrograde ejaculation is a frequent and permanent complication after bilateral retroperitoneal lymphadenectomy (RPLND). Seminal emission and ejaculation are primarily under sympathetic control. Several studies after RPLND in patients with nonseminomatous testis cancer proved the role of preservation of the efferent fibers originating from the lumbar sympathetic ganglia. Based on the results of anatomical studies, a modified unilateral operative technique and nerve-sparing approach permit to preserve normal anterograde ejaculation without reduction of long-term survival.


Subject(s)
Ejaculation , Erectile Dysfunction/etiology , Germinoma/surgery , Lymph Node Excision/adverse effects , Testicular Neoplasms/surgery , Ejaculation/physiology , Erectile Dysfunction/prevention & control , Ganglia, Sympathetic/physiology , Humans , Lymph Node Excision/methods , Male , Retroperitoneal Space , Time Factors
5.
Arch Ital Urol Androl ; 68(1): 21-4, 1996 Feb.
Article in Italian | MEDLINE | ID: mdl-8664915

ABSTRACT

OBJECTIVE: This study evaluates the outcome of patients (pts) with primary T1G3 bladder cancer treated by transurethral resection (TUR) alone or followed by intravesical prophylaxis (BCG/Doxorubicin). Cistectomy was considered at disease progression. METHODS: Between 1/89 and 5/95 thirty-one pts with primary T1G3 bladder cancer were treated by TUR, in 24 followed by intravesical prophylaxis (13 with BCG, 11 with Doxorubicin). 7 pts had only TUR. RESULTS: At 42 months median follow up 45.2% pts (14/31) are disease free. The recurrence rate was 25.8% (8/31) and progression of disease was seen in 29.0% (9/31); mortality rate was 22.6% (7/31). In 13/31 pts treated by TUR + BCG 53.8% pts (7/13) are disease free. The recurrance rate was 23.1% (3/13) and progression of disease was seen in 23.1% (3/13) of cases; mortality rate was 23.1% (3/13). In 11/31 pts treated by TUR+Doxorubicin 54.5% pts (6/11) are disease free. The recurrance rate was 18.2% (2/11), progression of disease was seen in 27.3% (3/11) of cases of mortality rate of 9.1% (1/11). In 7/31 pts treated by TUR alone 14.3% pts (1/7) are disease free. The recurrance rate was 42.9% (3/7) and progression of disease was seen in 42.9% (3/7) of cases and mortality rate of 42.9% (3/7). Cistectomy was considered in 4 pts (3 for disease progression and 1 because of no disease free interval). The other pts with progression were not treated surgically because of their poor performance status. CONCLUSION: At a 42 months median follow up 77.4% pts (24/31) are alive (83.3% pts treated by TUR+intravesical prophylaxis). 64.5% pts (20/31) still have their bladder (66.6% pts treated by TUR+intravesical prophylaxis (16/24). We did not find a significative difference between prophylaxis with immunotherapy or chemotherapy. In conclusion we believe that the conservative management of high risk bladder transitional cell carcinoma T1G3 is feasible and allow us to plan cistectomy only in pts with progression or recurrance with no free interval without losing survival.


Subject(s)
Carcinoma, Transitional Cell/therapy , Urinary Bladder Neoplasms/therapy , Administration, Intravesical , Antibiotics, Antineoplastic/administration & dosage , BCG Vaccine/administration & dosage , Carcinoma, Transitional Cell/mortality , Carcinoma, Transitional Cell/pathology , Combined Modality Therapy , Cystectomy , Disease-Free Survival , Doxorubicin/administration & dosage , Follow-Up Studies , Humans , Immunotherapy , Neoplasm Recurrence, Local , Prognosis , Risk Factors , Time Factors , Urinary Bladder/pathology , Urinary Bladder Neoplasms/mortality , Urinary Bladder Neoplasms/pathology
6.
Arch Ital Urol Androl ; 67(1): 75-7, 1995 Feb.
Article in Italian | MEDLINE | ID: mdl-7538395

ABSTRACT

Prostatic stenting is a therapeutic option in the management of obstruction in patients unfit for surgical treatment. At present different devices are available, permanent or temporary, the former being covered by epithelium. The Authors report their experience on 40 patients, 27 of which treated with Fabian spiral. They conclude considering that permanent stenting is likely to be a better solution; temporary spirals, however, give good results and can be the first choice in some situations.


Subject(s)
Prostatic Hyperplasia/therapy , Stents , Evaluation Studies as Topic , Follow-Up Studies , Humans , Male , Time Factors
7.
Arch Ital Urol Androl ; 66(4 Suppl): 77-80, 1994 Sep.
Article in Italian | MEDLINE | ID: mdl-7534169

ABSTRACT

The Authors report their experience in the diagnosis of prostatic carcinoma by means of DRE, TRUS and PSA. They emphasize the improvement of diagnosis given by these exams when used in association, despite a high rate of false positives. In the years 92-93, 182 patients underwent ecoguided prostatic biopsy after DRE and PSA evaluation. PSA density value was calculated as proposed by Benson (PSAD = PSA/V); this parameter should screen between PSA elevation due to BPH and those due to prostatic carcinoma. After their experience, even if limited, they conclude that TRUS should not be used as a "first-line test" but only in patients with abnormal findings in DRE and/or PSA. PSAD may be useful to improve specificity of PSA even if a precise cut-off can not be determined.


Subject(s)
Prostate-Specific Antigen/blood , Prostatic Neoplasms/diagnosis , Aged , Aged, 80 and over , Humans , Male , Middle Aged , Palpation , Prostatic Neoplasms/blood , Prostatic Neoplasms/diagnostic imaging , Sensitivity and Specificity , Ultrasonography
8.
Biomed Pharmacother ; 47(8): 345-52, 1993.
Article in English | MEDLINE | ID: mdl-8061256

ABSTRACT

We evaluated coagulation and fibrinolytic parameters in both plasma and ascitic fluid of 39 patients with ascites secondary to liver cirrhosis and in 14 cirrhotic patients without ascites, in order to verify if the peritoneal compartment could be involved in the pathogenesis of the hyperfibrinolytic state of the disease. An activation of fibrinolysis, as suggested by increased levels of FDP, D-dimer and tissue plasminogen activator (t-PA) was demonstrated in both ascitic fluid and to a lesser extent in plasma. A positive correlation was also observed between plasma and ascitic fluid plasminogen, anti-plasmin and fibrinogen, while a negative correlation was found between plasma and ascitic fluid plasminogen activator inhibitor-1 (PAI-1). Moreover, plasma PAI-1 was significantly lower in patients with ascites than in those without ascites and among ascitic patients in those who had bleeding into soft tissues when compared to those who did not present haemorrhagic events. Finally, a significant association was also shown between positivity for plasma D-dimer (> 200 ng/ml) and the presence of ascites. Taken together, our data suggest an exchange of some coagulation and fibrinolytic proteins between plasma and ascitic fluid and point out the key role of PAI-1 in regulating plasma fibrinolytic potential and in bleeding complications in cirrhotic patients.


Subject(s)
Ascites/etiology , Fibrinolysis , Liver Cirrhosis/metabolism , Adult , Aged , Ascitic Fluid/chemistry , Blood Coagulation Factors/analysis , Female , Humans , Liver Cirrhosis/blood , Liver Cirrhosis/complications , Male , Middle Aged , Plasminogen Activator Inhibitor 1/analysis , Plasminogen Activator Inhibitor 1/blood
9.
Clin Exp Allergy ; 20(6): 689-92, 1990 Nov.
Article in English | MEDLINE | ID: mdl-2083408

ABSTRACT

Food sensitization was evaluated in 78 subjects with respiratory allergies, both by skin tests with commercial and fresh allergens, and by specific IgE determination. On the basis of the presence or absence of the latter the population was divided into two groups. The group with food-specific IgE showed more severe features of respiratory allergy, including a greater number of positive skin tests and specific IgE determinations, more class 3 and 4 reactions, and more symptoms. The hypothesis that early food sensitization can predispose to severe inhalant allergy is discussed.


Subject(s)
Food Hypersensitivity/complications , Hypersensitivity/complications , Respiratory Tract Diseases/complications , Adult , Female , Food Hypersensitivity/diagnosis , Humans , Immunoglobulin E/analysis , Male , Skin Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...